Judge OKs $762 Million Deal in Aranesp Case - MedPage Today

[INCIID News Feed]

MiamiHerald.com
<img alt="" height="1" width="1" />
Judge OKs $762 Million Deal in Aranesp Case
MedPage Today
A federal judge approved a $762 million settlement Wednesday in a case involving Amgen&#39;s off-label promotion of darbepoetin alfa (Aranesp), an anemia drug. The biotech drug giant pled guilty Tuesday to promoting darbepoetin for off-label dosing regimens.
Amgen pleads guilty to improper marketing of anemia drug AranespLos Angeles Times
Amgen Workers Helped US in Marketing InquiryNew York Times
Amgen whistleblower went undercover for the fedsFiercePharma
Reuters -MarketWatch -Wealth Daily
all 392 news articles &raquo;


More...